Investors

2nd Annual Oligonucleotide and Peptide Therapeutics Conference

Mar 27 from 4:15 PM EDT to Mar 29, 2017

March 28, 2017, Oligonucleotide Discovery and Delivery Track
Pamela Pavco, PhD, Chief Development Officer, RXi Pharmaceuticals
4:15pm: Presentation - Self-Delivering RNAi Compounds for the Treatment of Ocular Disorders

March 29, 2017, Symposium 1: Oligonucleotides for Cancer Immunotherapy
Alexey Eliseev, PhD, Chief Business Officer, RXi Pharmaceuticals
1:25pm: Chair Session - Novel Immunomodulatory Nucleic Acids
1:30pm: Presentation - Targeting Immune Checkpoints Using Self-Delivering RNAi Technology

Location

Royal Sonesta Boston
Cambridge, MA